Stéphanie Falcao

Stéphanie Falcao, PhD has extensive work experience in the medical affairs field. Their most recent role is as the Medical Director for Canada at Bausch Health Companies Inc., a position they started in September 2022. Prior to that, they worked as the Associate Director of Medical Affairs for Biosimilars at Organon from June 2021 to September 2022, and at Merck from May 2018 to June 2021. Stéphanie also held various roles at Teva Pharmaceuticals from 2010 to 2018, including Associate Director of Medical Affairs, Medical Communications Manager, Medical and Scientific Advisor, and Medical Affairs Specialist. Stéphanie also served as a board member at Société Québécoise d'Hypertension Artérielle from 2008 to 2010.

Stéphanie Falcao, PhD, completed their education with a BSc in Biochemistry from the Université de Montréal in 2003. Stéphanie then went on to obtain an MSc in Pharmacology from the same university from 2004 to 2006. Continuing their academic pursuits, Stéphanie pursued a PhD in Biomedical Sciences at the Université de Montréal from 2006 to 2010. In 2013, they further enriched their knowledge by completing a Mini-MBA at the McGill University - Desautels Faculty of Management.